Concepedia

Giulio Sartori

GS

Statistics

Publications

15

Citations

396

H-Index

13

Active since

1968

Affiliations

Institute of Oncology Research(Current)

SIB Swiss Institute of Bioinformatics

Università della Svizzera italiana

Dalle Molle Institute for Artificial Intelligence Research

Centro di Riferimento Oncologico

Giulio Sartori is an author at Institute of Oncology Research specializing in oncology, molecular oncology, and pharmacology.

ORCID

Publications per year

1968–2023

15

Publications

15

The ETS Inhibitors YK-4-279 and TK-216 Are Novel Antilymphoma Agents

Filippo Spriano, Elaine Y. Chung, Eugenio Gaudio et al. · Clinical Cancer Research · 2019 · 69 citations

, , +17

Abrogation of EMILIN1-β1 integrin interaction promotes experimental colitis and colon carcinogenesis

Alessandra Capuano, Eliana Pivetta, Giulio Sartori et al. · Matrix Biology · 2019 · 42 citations · Full text

, , +17

Rifamycins LXI: In vivo inhibition of RNA synthesis by rifamycins

Giancarlo Lancini, Giulio Sartori · Cellular and Molecular Life Sciences · 1968 · 40 citations

, , +9

Targeting CD205 with the antibody drug conjugate MEN1309/OBT076 is an active new therapeutic strategy in lymphoma models

Eugenio Gaudio, Chiara Tarantelli, Filippo Spriano et al. · Haematologica · 2020 · 39 citations · Full text

, , +17

The extracellular matrix protein EMILIN1 silences the RAS-ERK pathway via α4β1 integrin and decreases tumor cell growth

Teresa Maria Elisa Modica, Orlando Maiorani, Giulio Sartori et al. · Oncotarget · 2017 · 33 citations · Full text

, , +17

1–5 of 15